当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:134.74亿  总市值:134.74亿
流通股本:11.99亿   总股本:11.99亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,160,388,744.468,563,322,286.315,791,576,436.272,722,682,572.54
  收到的税费返还12,275,558.113,156,921.236,656,615.082,041,364.04
  收到其他与经营活动有关的现金356,429,834.69389,705,714.36310,601,342.47118,896,415.48
  经营活动现金流入小计11,529,094,137.258,966,184,921.96,108,834,393.822,843,620,352.06
  购买商品、接受劳务支付的现金5,131,740,533.083,882,573,352.922,541,822,928.511,432,232,724.07
  支付给职工以及为职工支付的现金1,785,937,977.631,369,853,580.84960,409,709.4584,417,014.41
  支付的各项税费817,826,210.59602,712,320.28431,873,697210,531,098.21
  支付其他与经营活动有关的现金1,761,913,400.531,466,382,116.79963,693,649.24353,732,450.38
  经营活动现金流出小计9,497,418,121.837,321,521,370.834,897,799,984.152,580,913,287.07
  经营活动产生的现金流量净额2,031,676,015.421,644,663,551.071,211,034,409.67262,707,064.99
二、投资活动产生的现金流量:
  取得投资收益收到的现金11,544,40016,344,491.3311,544,400-
  处置固定资产、无形资产和其他长期资产收回的现金净额14,677,947.533,913,015.13,410,361.323,044,406.49
  收到的其他与投资活动有关的现金60,017,10055,136,592.373,416,283.821,529,219.45
  投资活动现金流入小计86,239,447.5375,394,098.818,371,045.144,573,625.94
  购建固定资产、无形资产和其他长期资产支付的现金376,395,257.64215,322,290.41112,627,963.2748,824,111.48
  投资支付的现金78,284,936.6555,784,936.6530,784,936.6525,000,000
  支付其他与投资活动有关的现金660,0002,960,022.352,229,894.351,086,791.4
  投资活动现金流出小计455,340,194.29274,067,249.41145,642,794.2774,910,902.88
  投资活动产生的现金流量净额-369,100,746.76-198,673,150.61-127,271,749.13-70,337,276.94
三、筹资活动产生的现金流量:
  取得借款收到的现金2,357,854,777.041,431,330,849.251,195,029,200.48569,343,230
  筹资活动现金流入小计2,357,854,777.041,431,330,849.251,195,029,200.48569,343,230
  偿还债务支付的现金3,558,356,912.962,292,217,7961,531,217,796613,000,000
  分配股利、利润或偿付利息支付的现金343,424,482.78323,720,682.87299,991,018.8727,731,374.33
  支付其他与筹资活动有关的现金89,461,043.4259,018,938.5956,613,187.871,679,317.36
  筹资活动现金流出小计3,991,242,439.162,674,957,417.461,887,822,002.74642,410,691.69
  筹资活动产生的现金流量净额-1,633,387,662.12-1,243,626,568.21-692,792,802.26-73,067,461.69
四、汇率变动对现金及现金等价物的影响-887,015.79231,228.83677,653.7559,053.48
  现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额28,300,590.75202,595,061.08391,647,512.03119,361,379.83
  加:期初现金及现金等价物余额1,189,884,406.711,189,884,406.71,189,884,406.71,189,884,406.7
  期末现金及现金等价物余额1,218,184,997.461,392,479,467.781,581,531,918.731,309,245,786.53
补充资料:
  净利润547,485,702.43-304,913,629.54-
  资产减值准备213,171,765.88-142,462,387.53-
  固定资产和投资性房地产折旧839,605,626.49-426,759,845.36-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧839,605,626.49-426,759,845.36-
  无形资产摊销119,836,009.25-57,508,038.08-
  长期待摊费用摊销2,950,260.29-1,540,903.45-
  处置固定资产、无形资产和其他长期资产的损失-5,234,365.98--305,012.36-
  固定资产报废损失2,619,979.32-325,243.78-
  公允价值变动损失34,782,686.47-35,878,704.73-
  财务费用102,918,776.73-53,587,757.24-
  投资损失34,724,323.36-29,880,317.54-
  递延所得税28,719,719.04-28,933,138.19-
  其中:递延所得税资产减少28,898,364.59-28,950,839.67-
    递延所得税负债增加-178,645.55--17,701.48-
  存货的减少66,089,346.39-128,612,507.42-
  经营性应收项目的减少33,090,521.08-108,333,202.62-
  经营性应付项目的增加-59,352,548.42--118,131,538.34-
  其他512,982.57-323,184.74-
  现金的期末余额1,218,184,997.46-1,581,531,918.73-
  减:现金的期初余额1,189,884,406.71-1,189,884,406.7-
  现金及现金等价物的净增加额28,300,590.75-391,647,512.03-
公告日期2026-04-082025-10-282025-08-262025-04-17
审计意见(境内)标准无保留意见
TOP↑